QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.104.008847v1 67/4/1045    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bruysters, M. Articles by Leurs, R. Search for Related Content PubMed PubMed Citation Articles by Bruysters, M. Articles by Leurs, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PYRILAMINE

Original Article

Pharmacological Differences between Human and Guinea Pig Histamine H₁ Receptors: Asn⁸⁴ (2.61) as Key Residue within an Additional Binding Pocket in the H₁ Receptor

Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (M.B., A.J., F.v.d.M., R.A.B., R.L.); and UCB S.A. Pharma Sector, Braine-l'Alleud, Belgium (M.G., P.C.)

Abstract

We tested several histamine H₁ receptor (H₁R) and antagonists for their differences in agonists binding affinities between human and guinea pig H₁Rs transiently expressed in African green monkey kidney (COS-7) cells. Especially, the bivalent agonist histaprodifen-histamine dimer (HP-HA) shows a higher affinity for guinea pig than for human H₁Rs. Based on the structure of HP-HA, we have further identified VUF 4669 [7-(3-(4-(hydroxydiphenylmethyl)piperidin-1-yl)propoxy)-4-oxochroman-2-carboxylic acid] as a guinea pig-preferring H₁R antagonist, demonstrating that the concept of species selectivity is not limited to agonists. To delineate the molecular mechanisms behind the observed species selectivity, we have created mutant human H₁Rs in which amino acids were individually replaced by their guinea pig H₁R counterparts. Residue Asn⁸⁴ (2.61) in transmembrane domain (TM) 2 seemed to act as a selectivity switch in the H₁R. Molecular modeling and site-directed mutagenesis studies suggest that Asn⁸⁴ interacts with the conserved Tyr⁴⁵⁸ (7.43) in TM7. Our data provide the first evidence that for some H₁R ligands, the binding pocket is not only limited to TMs 3, 4, 5, and 6 but also comprises an additional pocket formed by TMs 2 and 7.

Received for publication October 29, 2004.

Accepted for publication December 29, 2004.

Address correspondence to: Prof. Dr. R. Leurs, Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. E-mail: r.leurs{at}few.vu.nl

This article has been cited by other articles:

				K.-F. Deml, S. Beermann, D. Neumann, A. Strasser, and R. Seifert Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor Mol. Pharmacol., November 1, 2009; 76(5): 1019 - 1030. [Abstract] [Full Text] [PDF]

				H.-J. Wittmann, R. Seifert, and A. Strasser Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor Mol. Pharmacol., July 1, 2009; 76(1): 25 - 37. [Abstract] [Full Text] [PDF]

				A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor Mol. Pharmacol., March 1, 2009; 75(3): 454 - 465. [Abstract] [Full Text] [PDF]

				A. Strasser, H.-J. Wittmann, and R. Seifert Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 783 - 791. [Abstract] [Full Text] [PDF]

				A. Strasser, B. Striegl, H.-J. Wittmann, and R. Seifert Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 60 - 71. [Abstract] [Full Text] [PDF]

				S.-X. Xie, A. Kraus, P. Ghorai, Q.-Z. Ye, S. Elz, A. Buschauer, and R. Seifert N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1262 - 1268. [Abstract] [Full Text] [PDF]

				S.-X. Xie, P. Ghorai, Q.-Z. Ye, A. Buschauer, and R. Seifert Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 139 - 146. [Abstract] [Full Text] [PDF]